differences in semaglutide and tirzepatide vs Tirzepatide vs Semaglutide: Ultimate Weight

GLP-1 RAs are being studied [archived link] for use in many other medical conditions, including fatty liver disease, Parkinsons disease, and substance use disorders, among others

While the medication was prescribed presumably to address these two issues given their FDA approvals and clinical indications, the reason for prescription was not captured in the data

This tells us that slow initial response does not predict failure, a particularly relevant finding for microdosers who may not see dramatic changes in their early weeks at sub-therapeutic doses

Active Ingredient: Tirzepatide Tirzepatide is a dual agonist it activates GLP-1 receptors and GIP (glucose-dependent insulinotropic polypeptide) receptors

Protect against light